Minimally invasive vs. trans-sternal thymectomy for non-thymomatous myasthenia gravis: a multi-institutional longitudinal study examining neurologic outcomes
Our study confirms the results of the landmark MGTX (Randomized Trial of Thymectomy in Myasthenia Gravis) trial in a real-world multicenter experience. Similar outcomes were achieved regardless of surgical approach. These data support thymectomy for MG either by a minimally invasive or trans-sternal approach. This is the first study to compare disease-specific, rather than perioperative, outcomes of thymectomy via sternotomy <i>vs.</i> minimally invasive approach.
Authors
- Joseph D. Phillips (ORCID: https://orcid.org/0000-0001-9309-7726)
- Joshua A. Boys (ORCID: https://orcid.org/0000-0002-8023-4530)
- Linda W. Martin (ORCID: https://orcid.org/0000-0002-7951-5677)
- Betül Gündoğdu (ORCID: https://orcid.org/0000-0002-3786-3286)
- Rachel Williams (ORCID: https://orcid.org/0000-0002-1954-0256)
- Peter Tatum (ORCID: https://orcid.org/0000-0001-9655-155X)
- Matthew Elliot
- Kayla A. Fay
- Dustin M. Walters
- J. Hunter Mehaffey
- Ryan Hall
- Jared P. Beller
Institutions
- Tufts University (US)
- University of Connecticut (US)
- University of Virginia Health System (US)
- University of California San Diego (US)
- UConn Health (US)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/jtd-24-423
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00